The roles of TRiC/CCT have been studied in a broad range of diseases including Huntington’s disease, Parkinson’s disease, and cancers, reflecting the range of cellular processes supported by TRiC/CCT chaperone activity4,5. This evidence concerns the gene FLVCR2 and Huntington disease.